{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T12:49:42Z","timestamp":1680266982215},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.hlc.2016.11.018","type":"journal-article","created":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T05:17:51Z","timestamp":1483247871000},"page":"1051-1058","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study"],"prefix":"10.1016","volume":"26","author":[{"given":"Aisha","family":"Etaher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Redfern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Briffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Hammett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Lefkovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.hlc.2016.11.018_bib0110","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/01.CIR.102.11.1216","article-title":"It's time for a change to a troponin standard","volume":"102","author":"Jaffe","year":"2000","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.hlc.2016.11.018_bib0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol."},{"issue":"6","key":"10.1016\/j.hlc.2016.11.018_bib0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1067\/mhj.2002.124048","article-title":"European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials","volume":"144","author":"Apple","year":"2002","journal-title":"Am Heart J."},{"issue":"1","key":"10.1016\/j.hlc.2016.11.018_bib0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/heart.90.1.99","article-title":"Clinical implications of the new definition of myocardial infarction","volume":"90","author":"French","year":"2004","journal-title":"Heart."},{"issue":"16","key":"10.1016\/j.hlc.2016.11.018_bib0130","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol."},{"issue":"23","key":"10.1016\/j.hlc.2016.11.018_bib0135","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1161\/01.CIR.0000044342.50593.63","article-title":"Cardiac troponin elevations in patients without acute coronary syndrome","volume":"106","author":"Hamm","year":"2002","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.hlc.2016.11.018_bib0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/hrt.2005.071282","article-title":"Differential diagnosis of elevated troponins","volume":"92","author":"Korff","year":"2006","journal-title":"Heart."},{"issue":"5","key":"10.1016\/j.hlc.2016.11.018_bib0145","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1378\/chest.125.5.1877","article-title":"Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance","volume":"125","author":"Roongsritong","year":"2004","journal-title":"Chest."},{"issue":"12","key":"10.1016\/j.hlc.2016.11.018_bib0150","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1373\/clinchem.2009.130799","article-title":"Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure","volume":"55","author":"Kelley","year":"2009","journal-title":"Clin Chem."},{"issue":"11","key":"10.1016\/j.hlc.2016.11.018_bib0155","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0735-1097(03)00421-2","article-title":"Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes","volume":"41","author":"Ammann","year":"2003","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"10.1016\/j.hlc.2016.11.018_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/hrt.2010.195511","article-title":"Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events","volume":"97","author":"Jolly","year":"2011","journal-title":"Heart."},{"issue":"2","key":"10.1016\/j.hlc.2016.11.018_bib0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.CIR.102.2.211","article-title":"Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism","volume":"102","author":"Giannitsis","year":"2000","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.hlc.2016.11.018_bib0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/2048872614564083","article-title":"High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causality","volume":"4","author":"Chew","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"issue":"16","key":"10.1016\/j.hlc.2016.11.018_bib0175","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jacc.2015.02.044","article-title":"Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART Registry","volume":"65","author":"Melki","year":"2015","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.018_bib0180","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurheartj\/ehq456","article-title":"Troponin elevation in coronary vs. non-coronary disease","volume":"32","author":"Agewall","year":"2011","journal-title":"Eur Heart J."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.018_bib0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/2048872614538411","article-title":"Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk","volume":"3","author":"Sandoval","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"issue":"2","key":"10.1016\/j.hlc.2016.11.018_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amjmed.2013.09.031","article-title":"Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary","volume":"127","author":"Alpert","year":"2014","journal-title":"Am J Med."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.018_bib0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/KP.a2013.0284","article-title":"Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction","volume":"72","author":"Szymanski","year":"2014","journal-title":"Kardiol Pol."},{"issue":"3","key":"10.1016\/j.hlc.2016.11.018_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5694\/mja12.11854","article-title":"Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study","volume":"199","author":"Chew","year":"2013","journal-title":"Med J Aust."},{"issue":"9","key":"10.1016\/j.hlc.2016.11.018_bib0205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5694\/mja15.00504","article-title":"Survival after an acute coronary syndrome: 18-month outcomes from the Australian and New Zealand SNAPSHOT ACS study","volume":"203","author":"Brieger","year":"2015","journal-title":"Med J Aust."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.018_bib0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.amjmed.2013.12.020","article-title":"Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort","volume":"127","author":"Saaby","year":"2014","journal-title":"Am J Med."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950616317425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950616317425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T03:06:52Z","timestamp":1568689612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950616317425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1443950616317425"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2016.11.018","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2016.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}